Skip to main content
A

Axelife

Axelife offers the pOpmètre®, a non-invasive medical device that measures arterial stiffness using pulse wave velocity (PWV). This technology provides objective data on vascular age, enabling healthcare professionals to refine cardiovascular risk assessment and personalize patient treatment plans.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Cardiovascular disease is the leading cause of mortality globally, with traditional risk assessment methods often relying on a limited set of factors. Arterial stiffness, a key indicator of cardiovascular health, is frequently overlooked or difficult to quantify accurately in routine clinical practice. This gap hinders precise risk stratification and personalized treatment strategies for patients.

Solution

Axelife provides the pOpmètre®, a Class IIa medical device designed for the non-invasive measurement of arterial stiffness via pulse wave velocity (PWV). This technology serves as a gold standard for assessing cardiovascular health, enabling healthcare professionals to refine patient risk classification and tailor treatment plans. The device's operator-independent design and rapid measurement capabilities integrate seamlessly into clinical workflows, enhancing the efficiency of cardiovascular prevention efforts. By providing objective data on vascular age, the pOpmètre® also serves as a powerful patient education tool, promoting adherence to lifestyle modifications and therapeutic regimens.

Target Audience

The primary target audience includes cardiologists, diabetologists, nephrologists, general practitioners, and other healthcare professionals involved in cardiovascular risk assessment and patient management. It also serves clinics, hospitals, and multidisciplinary health centers seeking to enhance their preventive care offerings.

Features

  • Class IIa medical device for measuring Pulse Wave Velocity (PWV) using photoplethysmography (PPG) technology.
  • Non-invasive assessment of arterial stiffness, a key cardiovascular risk biomarker.
  • Operator-independent design ensures consistent and reproducible measurements without specialized training.
  • Integrated pOplog® software for data acquisition, processing, and visualization, including calculation of vascular age.
  • Compact and portable form factor (175 x 155 x 64 mm, 265g) for ease of use in various clinical settings.
  • CE Mark 1282 certification, indicating compliance with European medical device regulations.
  • Supported by over 30 scientific publications validating its efficacy and clinical utility.
  • Capable of measuring PWV, arterial stiffness, vascular age, Ankle Brachial Index (ABI), and Central Blood Pressures.
This profile is AI-generated and may contain inaccuracies.